Branded Generics Market will reach at a CAGR of 7.3% through 2026
Future Market Insights has announced the addition of the “Branded Generics Market: Global Industry Analysis and Opportunity Assessment 2016-2026" report to their offering.
Future Market Insights has announced the addition of the “Branded Generics Market: Global Industry Analysis and Opportunity Assessment 2016-2026" report to their offering.
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Branded</strong> <strong>Generics</strong> <strong>Market</strong>: Global Industry Analysis and<br />
Opportunity Assessment 2016-<strong>2026</strong><br />
May 2017<br />
Report Id : REP-GB-1260<br />
St<strong>at</strong>us : Jan-2017<br />
C<strong>at</strong>egory : Healthcare, Pharmaceuticals & Medical Devices<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved
About<br />
Future <strong>Market</strong> Insights<br />
Future <strong>Market</strong> Insights (FMI) is a premier provider <strong>of</strong> syndic<strong>at</strong>ed research reports, custom<br />
research reports, and consulting services. We deliver a complete packaged solution, which<br />
combines current market intelligence, st<strong>at</strong>istical anecdotes, technology inputs, valuable growth<br />
insights, aerial view <strong>of</strong> the competitive framework, and future market trends.<br />
We provide research services <strong>at</strong> a global as well as regional level; key regions include GCC,<br />
ASEAN, and BRIC.<br />
Our <strong>of</strong>ferings cover a broad spectrum <strong>of</strong> industries including Chemicals, M<strong>at</strong>erials, Energy,<br />
Technology, Healthcare, and Retail.<br />
We have a global presence with delivery centers across India specializing in providing global<br />
research reports and country research reports. FMI is headquartered out <strong>of</strong> London, U.K., with a<br />
st<strong>at</strong>e-<strong>of</strong>-the-art delivery center loc<strong>at</strong>ed in Pune, India. We combine our knowledge and learning<br />
from every corner <strong>of</strong> the world to distill it to one thing – the perfect solution for our client.<br />
Research Capabilities<br />
Sector Coverage<br />
<br />
<br />
<br />
<br />
Customized Research<br />
Syndic<strong>at</strong>ed Research<br />
Investment Research<br />
Social Media Research<br />
<br />
<br />
<br />
<br />
Automotive and Transport<strong>at</strong>ion<br />
Electronics, Semiconductor, and ICT<br />
Retail and Consumer Products<br />
Industrial Autom<strong>at</strong>ion and Equipment<br />
<br />
<br />
<br />
<br />
Chemicals & M<strong>at</strong>erials<br />
Food and Beverages<br />
Services and Utilities<br />
Energy, Mining, Oil, and Gas<br />
Customized<br />
Research<br />
Syndic<strong>at</strong>ed<br />
Research<br />
Investment<br />
Research<br />
Social Media<br />
Research<br />
Subscription Inform<strong>at</strong>ion<br />
For detailed subscription inform<strong>at</strong>ion please contact<br />
Hari. T (Sr. Manager - Global Business Development)<br />
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268<br />
Email: hari.t@futuremarketinsights.com<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved<br />
2
Research Methodology (1/2)<br />
System<strong>at</strong>ic Research Approach<br />
<strong>Market</strong> pr<strong>of</strong>iling<br />
Formul<strong>at</strong>ing discussion guide<br />
Developing list <strong>of</strong> respondents<br />
D<strong>at</strong>a collection<br />
D<strong>at</strong>a valid<strong>at</strong>ion<br />
4<br />
5<br />
3<br />
1<br />
2<br />
In-depth secondary research is used to<br />
ascertain overall market size, top<br />
industry players, top products, industry<br />
associ<strong>at</strong>ions, etc.<br />
PMR formul<strong>at</strong>es a detailed discussion<br />
guide to conduct expert and industry<br />
interviews<br />
PMR develops a list <strong>of</strong> industry players<br />
(manufacturers), distributors, retailers<br />
and industry experts<br />
PMR conducts interviews with industry<br />
experts, industry players, distributors<br />
and retailers<br />
D<strong>at</strong>a is valid<strong>at</strong>ed by triangul<strong>at</strong>ion<br />
method, wherein secondary, primary<br />
and PMR analysis contribute to the final<br />
d<strong>at</strong>a<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
D<strong>at</strong>a<br />
Collection<br />
D<strong>at</strong>a Filter<br />
& Analysis<br />
Identifying key opinion leaders<br />
Questionnaire design<br />
In-depth interviews<br />
Coverage across value chain<br />
<strong>Market</strong> participants<br />
Key strengths<br />
Product portfolio<br />
Mapping as per value chain<br />
Key focus segments<br />
A<br />
Primary<br />
Research<br />
C<br />
Company<br />
Analysis<br />
Research &<br />
Intelligence<br />
SOLUTION<br />
Actionable<br />
Insights<br />
B<br />
Desk<br />
Research<br />
<br />
<br />
<br />
<br />
<br />
<br />
Business<br />
Solution<br />
Key industry experts<br />
Channel study<br />
Developments<br />
<strong>Market</strong> dynamics<br />
Products<br />
Conclusions<br />
D<strong>at</strong>a analysis<br />
6<br />
D<strong>at</strong>a is scrutinized using MS-Excel to<br />
obtain qualit<strong>at</strong>ive and quantit<strong>at</strong>ive<br />
insights about the industry<br />
Primary Research #<br />
Secondary Research #<br />
Paid Public<strong>at</strong>ions#<br />
Insights<br />
7<br />
PMR delivers industry insights and<br />
inform<strong>at</strong>ion in the required form<strong>at</strong><br />
(PDF)<br />
<br />
<br />
<br />
<br />
Linkedin<br />
Zoominfo<br />
Salesforce<br />
Avention<br />
<br />
<br />
<br />
<br />
Company websites<br />
Company annual<br />
reports<br />
White papers<br />
Financial reports<br />
<br />
<br />
<br />
<br />
Factiva<br />
GBI<br />
Genios<br />
Meltw<strong>at</strong>er<br />
# includes sources <strong>of</strong> d<strong>at</strong>abases<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved<br />
3
<strong>Branded</strong> <strong>Generics</strong> <strong>Market</strong><br />
Global Sales <strong>of</strong> <strong>Branded</strong> <strong>Generics</strong> Will Amass More Than US$ 400 Billion in Revenues By <strong>2026</strong>-End<br />
A recent research conducted by Future <strong>Market</strong> Insights predicts th<strong>at</strong> the global market for branded<br />
generics <strong>will</strong> witness a steady growth in terms <strong>of</strong> revenues. Over a ten-year forecast period from 2016 to<br />
<strong>2026</strong>, the size <strong>of</strong> global branded generics market has been estim<strong>at</strong>ed to expand <strong>at</strong> a steady <strong>CAGR</strong> <strong>of</strong> <strong>7.3%</strong>.<br />
Brand-name prescriptions <strong>will</strong> continue to be ubiquitous among aged people in the world, and since<br />
geri<strong>at</strong>ric demographics account for a large portion <strong>of</strong> global drug-consuming popul<strong>at</strong>ion, demand for<br />
branded generics <strong>will</strong> also rise substantially. In 2016, the global branded generics market has been<br />
valued <strong>at</strong> nearly US$ 200 billion, and is projected to <strong>reach</strong> US$ 413.8 Bn market value by the end <strong>of</strong><br />
forecast period.<br />
Some <strong>of</strong> the leading manufacturers <strong>of</strong> branded generics are based in Asian countries, and are extending<br />
their production capacity to keep up with the surging global depend. In Asia-Pacific excluding Japan<br />
(APEJ) region, about US$ 150 billion revenues are expected to be procured by the end <strong>of</strong> <strong>2026</strong>. During<br />
the forecast period, branded generics market in the APEJ region <strong>will</strong> <strong>at</strong>tain fastest growth, registering a<br />
10% <strong>CAGR</strong>, contributing over 35% <strong>of</strong> global branded generics revenues. North America, Eastern Europe<br />
and L<strong>at</strong>in America are also expected to be lucr<strong>at</strong>ive for growth <strong>of</strong> branded generics sales, while revenues<br />
in Western Europe, Japan and Middle East & Africa (MEA) are likely to incur a considerable dip by <strong>2026</strong>-<br />
end.<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved 4
<strong>Branded</strong> <strong>Generics</strong> <strong>Market</strong><br />
Competitive Timeline in Global <strong>Branded</strong> <strong>Generics</strong> <strong>Market</strong><br />
Since 2015, Abbott Labor<strong>at</strong>ories, a leading drugmaker in the global pharmaceuticals industry, has<br />
aimed <strong>at</strong> capitalizing from branded generics businesses in developing regions.<br />
Teva Pharmaceuticals acquired Allergan’s branded generics vertical, while Pfizer Inc. bought Hospira<br />
Inc. – both acquisitions have been str<strong>at</strong>egically carried out for repositioning market standings <strong>of</strong> Teva<br />
and Pfizer respectively.<br />
In December 2016, India-based Sun Pharmaceuticals Industries Ltd. agreed to buy Swiss drugmaker<br />
Novartis AG’s branded generics portfolio on cancer medic<strong>at</strong>ions.<br />
Another leading branded generics manufacturer, Mylan N.V. recently launched anti-allergy devices<br />
which are expected to be half the price <strong>of</strong> its branded EpiPens.<br />
Other prominent companies partaking in the growth <strong>of</strong> global branded generics market include, Aspen<br />
Pharmacare Holding Ltd. and Valeant Pharmaceuticals Intern<strong>at</strong>ional, Inc.<br />
Research Highlights on Global <strong>Branded</strong> <strong>Generics</strong> <strong>Market</strong><br />
The report includes a segmental analysis <strong>of</strong> the global branded generics market, fragmenting its growth<br />
on the type <strong>of</strong> drug formul<strong>at</strong>ion, major drug classes, therapeutic applic<strong>at</strong>ions, and distribution channels.<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved 5
<strong>Branded</strong> <strong>Generics</strong> <strong>Market</strong><br />
Based on such segment<strong>at</strong>ion, some <strong>of</strong> the key findings compiled in the report are:<br />
Nearly three-fifth <strong>of</strong> the global branded generics revenues estim<strong>at</strong>ed in 2016 are expected to be<br />
accounted by oral-type formul<strong>at</strong>ions, with parenteral, topic and other formul<strong>at</strong>ion types collectively<br />
accounting for 8% market value share.<br />
Hospital pharmacies & retail pharmacies <strong>will</strong> remain as the largest distribution channels for branded<br />
generics <strong>through</strong>out the globe.<br />
In 2016 and beyond, the demand for branded generics in therapeutic tre<strong>at</strong>ment <strong>of</strong> cardiovascular<br />
diseases <strong>will</strong> be significant, revenues from which are expected to increase <strong>at</strong> more than 8% <strong>CAGR</strong> over<br />
the forecast period.<br />
Global revenues <strong>of</strong> branded generics accounted by anti-hypertensive drug class are predicted to<br />
surpass US$ 25 billion by <strong>2026</strong>-end.<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved 6
Table <strong>of</strong> Content<br />
1. Executive Summary<br />
2. <strong>Market</strong> Introduction<br />
2.1. <strong>Market</strong> Definition<br />
2.2. <strong>Market</strong> Taxonomy<br />
2.3. <strong>Generics</strong> <strong>Market</strong> Overview<br />
3. Global <strong>Branded</strong> <strong>Generics</strong> <strong>Market</strong> Analysis Scenario<br />
4. <strong>Market</strong> Dynamics<br />
3.1. <strong>Market</strong> Size (US$ Mn) and Forecast<br />
3.1.1. <strong>Market</strong> Size and Y-o-Y Growth<br />
3.1.2. Absolute $ Opportunity<br />
3.2. <strong>Market</strong> Overview<br />
3.2.1. Value Chain<br />
4.1. Macro-economic Factors<br />
4.2. Drivers<br />
4.2.1. Supply Side<br />
4.2.2. Demand Side<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved<br />
7
Table <strong>of</strong> Content<br />
4.3. Restraints<br />
4.4. Opportunity<br />
4.5. Forecast Factors – Relevance and Impact<br />
4.7.Regul<strong>at</strong>ions<br />
4.8.Porter Five Forces Model<br />
4.9.P<strong>at</strong>ennt expiries in 2016<br />
5. Global <strong>Branded</strong> <strong>Generics</strong> <strong>Market</strong> Analysis and Forecasts, By Therapeutic Applic<strong>at</strong>ion Type<br />
5.1. Introduction<br />
5.2. Basis Point Share (BPS) Analysis By Therapeutic Applic<strong>at</strong>ion Type<br />
5.3. Y-o-Y Growth Projections By Therapeutic Applic<strong>at</strong>ion Type<br />
5.4. <strong>Market</strong> Value Forecast By Therapeutic Applic<strong>at</strong>ion Type , 2016–<strong>2026</strong><br />
5.4.1. Oncology<br />
5.4.2. Cardiovascular Diseases<br />
5.4.3. Diabetes<br />
5.4.4. Neurology<br />
5.4.5. Gastrointestinal Diseases<br />
5.4.6. Derm<strong>at</strong>ology Di eases<br />
5.4.7. Analgesics and Anti-inflamm<strong>at</strong>ory<br />
5.4.8. Others<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved<br />
8
Table <strong>of</strong> Content<br />
5.5. Prominent Trends<br />
5.6. <strong>Market</strong> Attractiveness By Therapeutic Applic<strong>at</strong>ion Type<br />
6. Global <strong>Branded</strong> <strong>Generics</strong> <strong>Market</strong> Analysis and Forecasts, By Distribution Channel<br />
6.1. Introduction<br />
6.2. Basis Point Share (BPS) Analysis By Distribution Channel<br />
6.3. Y-o-Y Growth Projections By Distribution Channel<br />
6.4. <strong>Market</strong> Value Forecast By Distribution Channel, 2016–<strong>2026</strong><br />
6.4.1. Hospital Pharmacies<br />
6.4.2. Retail Pharmacies<br />
6.4.3. Online Pharmacies<br />
6.4.4. Drug Stores<br />
6.5. Prominent Trends<br />
6.6. <strong>Market</strong> Attractiveness By Distribution Channel<br />
7. Global <strong>Branded</strong> <strong>Generics</strong> <strong>Market</strong> Analysis and Forecasts, By Major Drug Classes<br />
7.1. Introduction<br />
7.2. Basis Point Share (BPS) Analysis By Major Drug Classes<br />
7.3. Y-o-Y Growth Projections By Major Drug Classes<br />
7.4. <strong>Market</strong> Value Forecast By Major Drug Classes, 2016–<strong>2026</strong><br />
7.4.1. Alkyl<strong>at</strong>ing Agents<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved<br />
9
Table <strong>of</strong> Content<br />
7.4.2. Antimetabolites<br />
7.4.3. Hormones<br />
7.4.4. Anti-Hypertensive<br />
7.4.5. Lipid Lowering Drugs<br />
7.4.6. Anti-Depressants<br />
7.4.7. Anti-Psychotics<br />
7.4.8. Anti-Epileptic<br />
7.4.9. Others<br />
7.5. Prominent Trends<br />
7.6. <strong>Market</strong> Attractiveness By Major Drug Classes<br />
8. Global <strong>Branded</strong> <strong>Generics</strong> <strong>Market</strong> Analysis and Forecasts, By Formul<strong>at</strong>ion Type<br />
8.1. Introduction<br />
8.2. Basis Point Share (BPS) Analysis By Formul<strong>at</strong>ion Type<br />
8.3. Y-o-Y Growth Projections By Formul<strong>at</strong>ion Type<br />
8.4. <strong>Market</strong> Value Forecast By Formul<strong>at</strong>ion Type , 2016–<strong>2026</strong><br />
8.4.1. Oral<br />
8.4.2. Parenteral<br />
8.4.3. Topical<br />
8.4.4. Others<br />
8.5. Prominent Trends<br />
8.6. <strong>Market</strong> Attractiveness By Formul<strong>at</strong>ion Type<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved<br />
10
To know more about us, please visit our website:<br />
www.futuremarketinsights.com<br />
For sales queries or new topics email us on:<br />
sales@futuremarketinsights.com<br />
For media queries, contact the press <strong>of</strong>fice <strong>at</strong><br />
press@futuremarketinsights.com<br />
For other queries contact:<br />
Hari. T (Sr. Manager - Global Business Development)<br />
Future <strong>Market</strong> Insights: 3rd Floor,<br />
207 Regent Street, London W1B 3HH<br />
T: +44 20 7692 8790 | D: +44 20 3287 4268<br />
Email: hari.t@futuremarketinsights.com<br />
Thank You<br />
Future <strong>Market</strong> Insights Global & Consulting Priv<strong>at</strong>e Limited (FMI)<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved<br />
11
Change language